Bayer Takes License For Homocysteine Assay
A unit of drug maker Bayer Group has agreed to take a license for a technology covering homocysteine assays, following Competitive Technologies' victory in its five-year patent infringement lawsuit against LabCorp...To view the full article, register now.
Already a subscriber? Click here to view full article